Focal defects (ulceration) of the gastrointestinal mucosa (the innermost layer of the GI tract that comes in contact with digested food chyme)
Peptic ulcer disease affects the stomach and/or duodenum (first part of the small intestine)
Causes of peptic ulcer disease
Worldwide and affects 5-10% of the population
H.pylori (bacteria)
Medications (NSAIDs, Corticosteroids)
Smoking (impairs healing)
Alcohol (irritates gastric mucosa)
Chronic stress
Vascular insufficiency
Helicobacter pylori
H. pylori burrow into the stomach lining, where they proliferate. Shielded by urease, an enzyme they secrete that produces ammonia, which neutralizes stomach acids.
Stressors/Vascular insufficiency
Can be a cause of ischemia to the lining of the stomach/duodenum or overreaction of the Vagus nerve (increases gastric acidity)
NSAIDs
Inhibit COX-1 enzyme, which reduces prostaglandin synthesis. Prostaglandins have a protective effect in the gastrointestinal mucosa.
Diagnosing peptic ulcer disease
EGD (esophagogastroduodenoscopy)
Assess for H. pylori Infection
Blood test
Stool Antigen (presence does not mean infection; just at one time they had it)
Urea Breath Test
Urea breath test
You swallow a pill that contains tagged carbon molecules. If you have H. pylori infection, carbon is released when the solution comes in contact with H. pylori in your stomach.
EGD is the gold standard for diagnosing peptic ulcer disease
Reducing acids in the GI tract
Antacids
PPI's
H2 Blockers
Mucosal Protectant
Treatment and drug classifications for peptic ulcer disease
Proton-Pump Inhibitor
Treat H. pylori (Triple Therapy - Clarithromycin, Amoxicillin, PPI)
Antibiotics
Histamine2-receptor antagonist
Mucosal Protectant
Antacids
Prostaglandin E analog
Histamine 2 - receptor antagonists
Blocks H2 receptors, which suppresses the secretion of gastric acid and lowers the concentration of hydrogen ions in the stomach
Cimetidine (Histamine 2 - receptor antagonist)
Blocks androgen receptors (sex hormones) - resulting in decreased sex drive, gynecomastia (males get enlarged breasts), and impotence (infertility)
Cimetidine is Pregnancy Risk Category B
Older adult clients are more likely to experience adverse CNS effects from Histamine 2 - receptor antagonists and can require a decreased dosage
Histamine 2 receptor antagonists decrease gastric acidity, which promotes bacterial colonization of the stomach and the respiratory tract
Histamine 2 receptor antagonists should be used cautiously in clients who are at high risk for pneumonia, including clients who have COPD
Dosages of Histamine 2 receptor antagonists should be reduced in clients with moderate to severe kidney impairment
Cimetidine can inhibit medication
Increases the levels of warfarin, phenytoin, theophylline, and lidocaine
When clients are taking warfarin, monitor for bleeding, monitor INR and PT levels
When clients are taking phenytoin, theophylline, and lidocaine, monitor blood levels
Concurrent use of Antacids can decrease absorption of Histamine 2 receptor antagonists
Client education for Histamine 2 - receptor antagonists
Do not take an antacid WITHIN 1 hr before, or after, taking a histamine2 receptor antagonist
Space administering of antacids to one hour before/after taking
Smoking can decrease the effectiveness of histamine 2 receptor antagonists. Nicotine is a vasoconstrictor that reduces blood flow to the skin, thereby resulting in tissue ischemia and impaired healing of injured tissues
Treatment of peptic ulcer disease
Usually started on an oral dose twice a day until the ulcer is healed, followed by a maintenance dose, which is usually taken once a day
Coffee-ground emesis is an indication of GI bleeding
Proton pump inhibitors
Blocks basal (occurs independently of eating and maintains at 1.5 to 3.5) and stimulated (the thought, smell, or taste of food effects vagal stimulation of the gastrin-secreting G cells located in the distal one-third [antrum] of the stomach) acid production and reduces gastric acid secretion by irreversibly inhibiting the enzyme that produces gastric acid
Therapeutic uses of proton pump inhibitors
Short-term therapy for gastric and duodenal ulcers, erosive esophagitis, and GERD. Treatment should be limited to 4 to 8 weeks.
PPIs can interfere with the absorption of magnesium and other vitamins. Monitor magnesium for long term use
Report fever, diarrhea, abdominal cramping, or bloody stools immediately to the provider, as these may indicate Clostridium difficile-associated diarrhea.
Proton pump inhibitors are Pregnancy Risk Category C
Use proton pump inhibitors cautiously with clients who have dysphagia or liver disease
Proton pump inhibitors increase the risk for pneumonia.
Digoxin, Methotrexate, Diazepam, Tacrolimus, Antifungal Agents, and Phenytoin levels
Can increase when used concurrently with omeprazole
Absorption of ketoconazole, itraconazole, and atazanavir is decreased when taken concurrently with a proton pump inhibitor. Avoid concurrent use. If necessary to administer concurrently, separate administering of the medications by 2 to 12 hours.
The beneficial effects of clopidogrel (anti-platelet) can decrease with concurrent use of a proton pump inhibitor. Monitor for thrombotic events.
Mucosal protectant (Sucralfate)
The acidic environment of the stomach and duodenum changes sucralfate into a protective barrier that adheres to an ulcer. This protects the ulcer from further injury from acid and pepsin. This viscous substance can stick to the ulcer for up to 6 hours.
Sucralfate protects the esophageal lining
Therapeutic uses of sucralfate
Treatment of acute duodenal ulcers and maintenance therapy. Neutralizes or reduces the acidity of gastric acid; can reduce pepsin activity if the pH is raised above 5.
Sucralfate can interfere with the absorption of
phenytoin, digoxin, warfarin, and ciprofloxacin
Maintain 2–3-hour interval between these medications and sucralfate to minimize the interaction